Replies to post #188451 on Biotech Values

[willyw]

In addition ENTA is depending on the income to fund the wave 4 HCV program.

The ABBV NS5a is very good; 4.5 log drop in monotherapy, and is nicely matched to 493.

I agree that Luly seemed very pleased w/ ENTA's NS5a. It could be as good or better than ABT-530.